North America Exosome Diagnostic and Therapeutic Market Growth Drivers and Forecast by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North America Exosome Diagnostic and Therapeutic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Application (Diagnostic and Therapeutic); Product (Instruments, Reagents, and Software); End User (Cancer Institute, Hospitals, Diagnostic Centers, and Other End Users), and Country

Report Date : Apr 2020
Report Code : TIPRE00010411

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 82

Page Updated: Apr 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The exosome diagnostic and therapeutic market in North America is expected to grow from US$ 17,578.32 thousand in 2019 to US$ 154,116.95 thousand by 2027. This represents a CAGR of 32.5% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to increased demand for the use of exosomes as biomarkers in the diagnosis of cancer, increasing prevalence of cancer, aging population and lifestyle changes. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the North American exosome diagnostic and therapeutic market during the forecast period.

The US has observed fast growth in the exosome diagnostic and therapeutic market within the past few years and is expected to lead the market in North America during the forecast period. Currently, exosomes are rapidly gaining momentum in accessing therapeutic effects of stem cells. Additionally, they hold great promise for use as biomarkers in non-invasive tests, vehicles for drug delivery, and active agents in cosmeceutical products. Investment has also increased in manufacturing technologies to support the production of clinical-grade stem cell exosomes. For instance, in 2017, RoosterBio and Exopharm collaborated on a Stem Cell Exomere Program. The objective of the project is to develop therapeutic extracellular exosomes derived from adult stem cells into clinical practice. Licensing activity has also increased in the industry offering lucrative opportunities for the growth of the market in the US. Further, in 2014, Capricor Therapeutics added seven new patent applications with Cedars-Sinai Medical Center for technologies related to cardiosphere-derived cells (CDCs) and CDC-derived extracellular vesicles, including exosomes.

US Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (US$ Thousand)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC – MARKET SEGMENTATION

North America Exosome Diagnostic and Therapeutic Market - By Application

Diagnostic
Therapeutic

North America Exosome Diagnostic and Therapeutic Market - By Product

Instruments
Reagents
Software

North America Exosome Diagnostic and Therapeutic Market - By End User

Cancer Institutes
Hospitals
Diagnostic Centers
Others

North America Exosome Diagnostic and Therapeutic Market - By Country

US
Canada
Mexico

Company Profiles

AETHLON MEDICAL, INC
BIOREGENERATIVE SCIENCES
Cell Guidance Systems
Evomic Science LLC
EXOSOME DIAGNOSTICS
ITH, Immune Therapy Holdings AB
Miltenyi Biotec
Norgen Biotek Corp
RENEURON GROUP PLC
Therapeutic Solutions International, Inc.

North America Exosome Diagnostic and Therapeutic Report Scope

Report Attribute	Details
Market size in 2019	US$ 17,578.32 thousand
Market Size by 2027	US$ 154,116.95 thousand
Global CAGR (2020 - 2027)	32.5%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Application Diagnostic and Therapeutic By Product Instruments Reagents Software By End User Cancer Institute Hospitals Diagnostic Centers Other End Users
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	AETHLON MEDICAL, INC BIOREGENERATIVE SCIENCES Cell Guidance Systems Evomic Science LLC EXOSOME DIAGNOSTICS ITH, Immune Therapy Holdings AB Miltenyi Biotec Norgen Biotek Corp RENEURON GROUP PLC

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Exosome Diagnostic and Therapeutic Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy